Possible New Coronavirus Vaccine Made Without Using Cells From Aborted Babies
Possible New Coronavirus Vaccine Made Without Using Cells From Aborted Babies – LifeNews.com
A potential coronavirus vaccine being tested in Australia could be the ethical alternative that pro-life advocates have been asking for. So far, the vaccine from Oxford University/AstraZeneca has been considered the most promising for COVID-19, but researchers are using cells from aborted babies in their testing – a huge ethical concern for pro-lifers.
Vaccine Company Sanofi-Pasteur Stops Using Aborted Baby Parts to Make Polio Vaccine – LifeNews.com
Pro-life advocates’ calls to stop producing vaccines with cells from aborted babies are making a difference in the world. The Catholic News Agency reports the company Sanofi-Pasteur just announced plans to produce a new, ethically-developed polio vaccine. The project will replace an older polio vaccine that was developed with cells from an aborted baby, according […]
Possible New Coronavirus Vaccine Made With Cells Taken From Aborted Babies – LifeNews.com
Prominent bioethics groups are raising concerns about a potential new coronavirus vaccine because British scientists used material from aborted babies to make it. According to Crux Now, the Oxford University research project has many hoping for success after a human trial began last week. However, the scientists used cell lines derived from aborted babies in […]
An Ethics Assessment of COVID-19 Vaccine Programs – Lozier Institute
Latest COVID-19 Vaccine Chart This is Issue 46 in CLI’s On Point Series. To view this report as a PDF, see: On Point 46: An Ethics Assessment of COVID-19 Vaccine Programs This page outlines the ethical considerations involved solely in vaccine production, based on information present at the time of publication.
Trump Admin Funding Pro-Life Alternatives to Using Aborted Baby Parts for Research – LifeNews.com
The Trump administration issued a plan Monday to promote ethical alternatives to aborted baby body parts in scientific research. The grants, under the National Institute of Health, will provide $20 million to develop alternatives to “human fetal tissue obtained from elective abortions,” according to the notice published Monday by the U.S.
